IMM News: Immutep Presents New and Significant Data from the AIPAC Study - 4th May 2022, 10:00pm

annb0t

Top 20
Immutep Limited

Statistically significant increase in innate and adaptive immune response biomarkers (monocyte and CD8 T cell counts and serum CXCL10 levels) and absolute lymphocyte count (ALC) demonstrated in the efti group, but not in the placebo group The increase in pharmacodynamic markers is significantly linked to improved OS Exploratory analysis identified six patient subgroups with improvements in Overall Survival (OS) which are relevant for patient population selection for future late-...

>>> Read more: Immutep Presents New and Significant Data from the AIPAC Study
 
Top Bottom